🧠 Your Voice, Your Questions, Our Next Moves in 340B

We’re gathering feedback from covered entities regarding recent Sanofi 340B purchase inquiries. Your responses will help us identify common experiences and support best practices across the program.

This quick poll asks:

• Whether you received a Sanofi inquiry in July 2024.

• If you responded, and how.

• Any additional follow-up you may have had with Sanofi.

Your input is invaluable in building a clearer picture of manufacturer outreach and its impact on 340B entities. Please take a few minutes to share your experience.